| Members |
targetComponentId |
| Oxacillin sodium 250mg/5mL powder for oral solution (product) |
Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Oxford Knee Score version 1.0 score (observable entity) |
Oxford Knee Score using revised scoring system (observable entity) |
| Oxidase |
Oxidase |
| Oxo-acid-lyase |
Oxo-acid-lyase |
| Oxybuprocaine 0.4% eye drops (product) |
Product containing only oxybuprocaine (medicinal product) |
| Oxybuprocaine hydrochloride 0.4% conventional release eye drops |
Product containing only oxybuprocaine (medicinal product) |
| Oxybuprocaine hydrochloride 0.4% single-use eye drops (product) |
Product containing only oxybuprocaine (medicinal product) |
| Oxybutynin 3.9mg/day transdermal system (product) |
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| Oxybutynin hydrochloride 15mg m/r tablet (product) |
Oxybutynin only product in oral dose form |
| Oxybutynin hydrochloride 15mg prolonged-release oral tablet |
Oxybutynin only product in oral dose form |
| Oxycodone hydrochloride 160mg m/r tablet (product) |
Product containing only oxycodone in oral dose form (medicinal product form) |
| Oxycodone hydrochloride 160mg prolonged-release oral tablet (product) |
Product containing only oxycodone in oral dose form (medicinal product form) |
| Oxygenase |
Oxygenase |
| Oxymetazoline hydrochloride 0.025% nose drops (product) |
Oxymetazoline hydrochloride 250 microgram/mL nasal solution |
| Oxymetazoline hydrochloride 0.05% eye drops (product) |
Oxymetazoline hydrochloride 500 microgram/mL eye solution |
| Oxymetazoline hydrochloride 0.05% nose drops (product) |
Oxymetazoline hydrochloride 500 microgram/mL nasal solution |
| Oxymorphone 10mg m/r tablet (product) |
Oxymorphone only product in oral dose form |
| Oxymorphone 10mg prolonged-release oral tablet (product) |
Oxymorphone only product in oral dose form |
| Oxymorphone 20mg m/r tablet (product) |
Oxymorphone only product in oral dose form |
| Oxymorphone 20mg prolonged-release oral tablet |
Oxymorphone only product in oral dose form |
| Oxymorphone 40mg m/r tablet (product) |
Oxymorphone only product in oral dose form |
| Oxymorphone 40mg prolonged-release oral tablet |
Oxymorphone only product in oral dose form |
| Oxymorphone 5mg m/r tablet (product) |
Oxymorphone only product in oral dose form |
| Oxymorphone 5mg prolonged-release oral tablet |
Oxymorphone only product in oral dose form |
| Oxytocic preparation (product) |
Medicinal product acting as oxytocic (product) |
| Oxytocin 10unt infusion solution 1mL vial (product) |
Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Oyster - dietary |
Oyster (substance) |
| PEG-intron redipen 120micrograms powder+sterile water 0.5mL (product) |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
| PEG-intron redipen 150micrograms powder+sterile water 0.5mL (product) |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
| PEG-intron redipen 50micrograms powder+sterile water 0.5mL (product) |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
| PEG-intron redipen 80micrograms powder+sterile water 0.5mL (product) |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
| PIE syndrome |
Simple pulmonary eosinophilia |
| Packing - action |
action : insertion |
| Paclitaxel 1mcg/mm drug eluting stent (product) |
Paclitaxel 1 microgram/mm2 drug eluting stent (product) |
| Painful ejaculation |
Painful ejaculation (finding) |
| Palatal flap |
Flap (substance) |
| Palatoplasty |
Uvulopalatopharyngoplasty |
| Pancreas excision |
pancréatectomie (intervention) |
| Pancrelipase, amylase:lipase 183.49mg capsule (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 184.84mg capsule (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 210.33mg capsule (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 278.72% capsule (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 312.17mg capsule (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 346.86mg capsule (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 4500unit capsule (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 62.81% (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 62.81% capsule (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pancrelipase, amylase:lipase 94.3mg capsule (product) |
Amylase and pancrelipase and triacylglycerol lipase only product |
| Pantoprazole sodium 40mg injection (product) |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |
| Pantoprazole sodium 40mg m/r tablet (product) |
Pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant oral tablet |
| Pantoprazole sodium 40mg powder (product) |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |
| Pantoprazole sodium 40mg/vial powder for injection (product) |
Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial |
| Papain specific extract (product) |
Product containing papain (medicinal product) |
| Papaya - dietary |
Papaya (substance) |
| Paphosia adorabilis |
Lophornis adorabilis (organism) |
| Papillary cystadenoma, borderline malignancy (morphologic abnormality) |
Papillary cystadenoma, borderline malignancy |
| Papillary mucinous cystadenoma, borderline malignancy |
Papillary mucinous cystadenoma, borderline malignancy |
| Papillary serous cystadenocarcinoma |
Serous cystadenocarcinoma |
| Papillary serous cystadenoma, borderline malignancy |
Serous papillary cystic tumor of borderline malignancy |
| Papilloma, no International Classification of Diseases for Oncology subtype (except papilloma of bladder M-81201) (morphologic abnormality) |
Benign papilloma (morphologic abnormality) |
| Para-aminophenol derivative anti-inflammatory agent (substance) |
Para-aminophenol derivative |
| Paracetamol + chlorpheniramine maleate + phenylephrine hydrochloride 500mg/8mg/40mg |
Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product) |
| Acetaminophen + orphenadrine citrate 500mg/50mg |
Acetaminophen and orphenadrine only product |
| Paracetamol - chemical (substance) |
Product containing paracetamol (medicinal product) |
| Paracetamol 1g/sachet powder (product) |
Acetaminophen only product |
| Paracetamol 1g/sachet powder (product) |
Acetaminophen only product |
| Paracetamol 500mg soluble tablet (product) |
Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
| Paracetamol 650mg / pentazocine hydrochloride 25mg caplet (product) |
Acetaminophen 650 mg and pentazocine 25 mg oral tablet |
| Paracetamol 650mg / pentazocine hydrochloride 25mg conventional release oral tablet (product) |
Acetaminophen 650 mg and pentazocine 25 mg oral tablet |
| Paracetamol+caffeine 500mg/65mg soluble tablet (product) |
Acetaminophen 5 mg/mL and caffeine 650 microgram/mL oral solution |
| Parafunctional occlusal trauma |
Secondary occlusal trauma |
| Parahyaena brunnea (organism) |
Hyaena brunnea (organism) |
| Paramyxovirus |
Genus Respirovirus (organism) |
| Paramyxovirus group |
Genus Respirovirus (organism) |
| Paraplegia, brachydactyly, cone-shaped epiphysis syndrome (disorder) |
ataxie spastique autosomique récessive de Charlevoix-Saguenay |
| Parascapular fasciocutaneous flap |
Fasciocutaneous flap |
| Parascapular fasciocutaneous flap plus scapula |
Osteofasciocutaneous flap (substance) |
| Parathormone |
Intact parathyroid hormone (substance) |
| Parecoxib 40mg (injection pdr for recon) (product) |
Parecoxib only product |
| Parecoxib 40mg injection (pdr for recon)+diluent (product) |
Parecoxib only product |
| Parecoxib 40mg injection (pdr for recon)+diluent (product) |
Parecoxib only product |
| Parenteral glyceryl trinitrate allergy |
Allergy to nitroglycerin |
| Parenteral intake process |
Administration of substance (procedure) |
| Parenteral isoprenaline allergy |
Allergy to isoprenaline |
| Parenteral isosorbide dinitrate allergy |
Allergy to isosorbide (finding) |
| Parenteral potassium allergy |
Propensity to adverse reaction to potassium (finding) |
| Parkinson-dementia complex of Guam |
Amyotrophic lateral sclerosis, parkinsonism, dementia complex |
| Paromomycin (substance) |
paromomycine (substance) |
| Paroophoron |
Wolffian body rest |
| Paroxetine 12.5mg gastro-resistant and prolonged-release oral tablet |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 12.5mg tablet controlled-release (product) |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 25mg gastro-resistant and prolonged-release oral tablet (product) |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 25mg tablet controlled-release (product) |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 37.5mg gastro-resistant and prolonged-release oral tablet (product) |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 37.5mg tablet controlled-release (product) |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine hydrochloride 10mg tablet (product) |
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
| Paroxetine mesylate 10mg tablet (product) |
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
| Paroxysmal kinesigenic choreoathetosis (disorder) |
choréoathétose familiale paroxystique |
| Parsley - dietary |
Parsley (substance) |
| Parsley - dietary (substance) |
Parsley (substance) |
| Partial avulsion of nail |
Partial excision of nail and nail matrix |
FHIR